Biotech · Public company · Stafford, TX, US
Greenwich LifeSciences, Inc.
Ticker GLSI · SEC CIK 0001799788
Track this companyFree. Adds Greenwich LifeSciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- GLSI-100Phase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsPHASE3 · RECRUITING · started Dec 16, 2022ClinicalTrials.gov NCT05232916 · fetched Nov 12, 2026
SEC filings11
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jun 4, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Jun 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 18, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 14, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 14, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 24, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 20, 2025 · fetched Nov 12, 2026
- 10-KSEC EDGAR · filed Apr 15, 2025 · fetched Nov 12, 2026
- 8-KSEC EDGAR · filed Dec 19, 2024 · fetched Nov 12, 2026
- 10-QSEC EDGAR · filed Nov 14, 2024 · fetched Nov 12, 2026